Researcher profile

Pierre Magal

Pierre Magal contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 19 - UnverifiedVerification L1Unclaimed author
5works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

5 published item(s)

preprint2022arXiv

Return-to-home model for short-range human travel

In this work, we develop a mathematical model to describe the local movement of individuals by taking into account their return to home after a period of travel. We provide a suitable functional framework to handle this system and study the large-time behavior of the solutions. We extend our model by incorporating a colonization process and applying the return to home process to an epidemic.

preprint2020arXiv

A Holling's predator-prey model with handling and searching predators

The goal of this paper is to explain how to derive the classical Rosenzweig-MacArthur's model by using a model with two groups of predators in which we can separate the vital dynamic and consumption of prey to describe the behavior of the predators. This will be especially very convenient if we want to add an age or size structure to the predator population. As mentioned by Holling (without mathematical model), we divide the population of predators into the searching and the handling predators. In this article we study some properties of this model and conclude the paper proving that the model converges to the classical Rosenzweig-MacArthur's model by using an appropriate rescalling. This convergence property is observed by using numerical simulations.

preprint2020arXiv

Predicting the cumulative number of cases for the COVID-19 epidemic in China from early data

We model the COVID-19 coronavirus epidemic in China. We use early reported case data to predict the cumulative number of reported cases to a final size. The key features of our model are the timing of implementation of major public policies restricting social movement, the identification and isolation of unreported cases, and the impact of asymptomatic infectious cases.

preprint2020arXiv

Sharp discontinuous traveling waves in a hyperbolic Keller--Segel equation

In this work we describe a hyperbolic model with cell-cell repulsion with a dynamics in the population of cells. More precisely, we consider a population of cells producing a field (which we call "pressure") which induces a motion of the cells following the opposite of the gradient. The field indicates the local density of population and we assume that cells try to avoid crowded areas and prefer locally empty spaces which are far away from the carrying capacity. We analyze the well-posedness property of the associated Cauchy problem on the real line. We start from bounded initial conditions and we consider some invariant properties of the initial conditions such as the continuity, smoothness and monotonicity. We also describe in detail the behavior of the level sets near the propagating boundary of the solution and we find that an asymptotic jump is formed on the solution for a natural class of initial conditions. Finally, we prove the existence of sharp traveling waves for this model, which are particular solutions traveling at a constant speed, and argue that sharp traveling waves are necessarily discontinuous. This analysis is confirmed by numerical simulations of the PDE problem.

preprint2010arXiv

Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model

Cancer is a proliferation disease affecting a genetically unstable cell population, in which molecular alterations can be somatically inherited by genetic, epigenetic or extragenetic transmission processes, leading to a cooperation of neoplastic cells within tumoral tissue. The efflux protein P-glycoprotein (P gp) is overexpressed in many cancer cells and has known capacity to confer multidrug resistance to cytotoxic therapies. Recently, cell-to-cell P-gp transfers have been shown. Herein, we combine experimental evidence and a mathematical model to examine the consequences of an intercellular P-gp trafficking in the extragenetic transfer of multidrug resistance from resistant to sensitive cell subpopulations. We report cell-to-cell transfers of functional P-gp in co-cultures of a P-gp overexpressing human breast cancer MCF-7 cell variant, selected for its resistance towards doxorubicin, with the parental sensitive cell line. We found that P-gp as well as efflux activity distribution are progressively reorganized over time in co-cultures analyzed by flow cytometry. A mathematical model based on a Boltzmann type integro-partial differential equation structured by a continuum variable corresponding to P-gp activity describes the cell populations in co-culture. The mathematical model elucidates the population elements in the experimental data, specifically, the initial proportions, the proliferative growth rates, and the transfer rates of P-gp in the sensitive and resistant subpopulations. We confirmed cell-to-cell transfer of functional P-gp. The transfer process depends on the gradient of P-gp expression in the donor-recipient cell interactions, as they evolve over time. Extragenetically acquired drug resistance is an additional aptitude of neoplastic cells which has implications in the diagnostic value of P-gp expression and in the design of chemotherapy regimens